Immunohistochemical detection of incipient melanoma micrometastases. Relationship with sentinel lymph node involvement.

Adult; Animals; Female; Humans; Immunohistochemistry; Lymph Nodes/pathology; Lymphatic Metastasis; Male; Melanoma/pathology/secondary; Middle Aged; Neoplasm Invasiveness; Rabbits; Sentinel Lymph Node Biopsy; Skin Neoplasms/pathology

Abstract :

[en] It is acknowledged that tumour thickness, ulceration and lymph node invasion are the most important prognostic factors for cutaneous melanomas. Other histopathological features may also be informative. The aim of this study was to ascertain whether immunohistochemical methods can improve the detection of satellite micrometastases in primary melanoma patients. In addition, the predictive value of cutaneous satellite micrometastases for sentinel lymph node involvement was evaluated. A total of 265 primary cutaneous melanomas and 68 of the respective sentinel nodes were studied using a panel of seven antibodies directed against melanocyte-related antigens. In 12.4% of the 265 cases, small satellite micrometastases were detected by immunohistochemistry. Sentinel lymph node metastases were found in 14% of the 68 cases. Invasion of the sentinel lymph node correlated with the presence of cutaneous satellite micrometastases. It is concluded that the presence of cutaneous satellite micrometastases may be an indication for the performance of sentinel lymph node biopsy, and this finding calls for a closer follow-up of these patients.

Disciplines :

Dermatology

Author, co-author :

Claessens, Nadine; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Pierard, Claudine ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Arrese Estrada, Jorge ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Quatresooz, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

English

Title :

Immunohistochemical detection of incipient melanoma micrometastases. Relationship with sentinel lymph node involvement.

Publication date :

2005

Journal title :

Melanoma Research

ISSN :

0960-8931

eISSN :

1473-5636

Publisher :

Lippincott Williams & Wilkins, London, United Kingdom

Volume :

Issue :

Pages :

107-10

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 25 March 2009

Statistics

Number of views

96 (9 by ULiège)

Number of downloads

4 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19:3635-3648.
Balch CM, Soong SJ, Gersherwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factor analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19:3622-3634.
Piérard GE, Arrese JE, Piérard-Franchimont C, Nikkels AF, Groupe Mosan d'Etude des Tumeurs Pigmentaires. How I explore... the risk of metastasis from melanoma. Rev Med Liège 2001; 56:120-123.
Pièrard-Franchimont C, Piérard GE. Karyometry of primary and metastatic melanoma. A correlation with cell proliferation. Am J Dermatopathol 1994; 16:247-252.
Piérard-Franchimont C, Arrese JE, Nikkels AF, Al-Saleh W, Delvenne P, Piérard GE. Factor XIIIa-positive dermal dendrocytes and proliferate activity of cutaneous cancers. Virchows Arch 1996; 429:43-48.
Piérard GE. Piérard-Franchimont C. Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas. Eur J Cancer 1997; 33:1888-1892.
Fullen DR, Headington JT. Factor XIIIa-positive dermal dendritic cells and HLA-DR expression in radial versus vertical growth phase melanomas. J Cutan Pathol 1998; 25:553-558.
Piérard-Franchimont C, Henry F, Heymans O, Piérard GE. Vascular retardation in dormant growth-stunted malignant melanomas. Int J Mol Med 1999; 4:403-406.
Moretti S, Spallanzani A, Chiarugi A, Fabiani M, Pinzi C. Correlation of Ki-67 expression in cutaneous primary melanoma with prognosis in a prospective study: different correlation according to thickness. J Am Acad Dermatol 2001; 44:188-192.
Alonso SR, Ortiz P, Pollan M, Pérez-Gomez B, Sanchez L, Jesus Acuna M, et al. Progression in cutaneous malignant melanoma is associated with distinct expression profiles. A tissue microarray-based study. Am J Pathol 2004; 164:193-203.
Quatresooz P, Arrese JE, Piérard-Franchimont C, Piérard GE. Immunohistochemical aid at risk stratification of melanocytic neoplasms. Int J Oncol 2004; 24:211-216.
Harrist TJ, Rigel DS, Day CL, Dubin N. "Microscopic satellites" are more highly associated with regional lymph node metastases than is primary melanoma thickness. Cancer 1984; 53:2183-2187.
Leon P, Daly JM, Synnestvedt M, Schultz DJ, Elder DE, Clark WJ. The prognostic implications of microscopic satellites in patients with clinical stage I melanoma. Arch Surg 1991; 126:1461-1468.
Weissman A, Roses DF, Harris MN, Dubin N. Prediction of lymph node metastases from the histologic features of primary cutaneous malignant melanomas. Am J Dermatopathol 1984; 6:S35-S41.
Mraz-Gernhard S, Sagebiel RW, Kashani-Sabet M, Miller JR 3rd, Leong SP. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. Arch Dermatol 1998; 134: 983-987.
McMasters KM, Wong SL, Edwards MJ, Ross MI, Chao C, Noyes RD, et al. Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery 2001; 130:151-156.
Lugassy C, Shahsafaei A, Bonitz P, Busam KJ, Barnhill RL. Tumor microvessels in melanoma express the beta-2-chain of laminin. Implications for melanoma metastasis. J Cutan Pathol 1999; 26:222-226.
Schaumburg-Lever G, Lever I, Fehrenbacker B, Möller H, Bischof B, Kaiserling E, et al. Melanocytes in nevi and melanomas synthesize basement and membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy. J Cutan Pathol 2000; 27:67-75.
Perrott RE, Glass LF, Reinigen DS, Fenske NA. Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma. J Am Acad Dermatol 2003; 49:567-588.
Bedrosian I, Faries MB, Guerry D, Elenitsas R, Schuchter L, Mick R, et al. Incidence of sentinel node metastasis in patients with thin primary melanoma (≤ 1 mm) with vertical growth phase. Ann Surg Oncol 2000; 7:262-267.
Statius Muller MG, van Leeuwen PAM, van Diest PJ, Vuylsteke RJCLM, Pijpers R, Meijer S. No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm. Melanoma Res 2001; 11:303-307.
Zapas JL, Coley HC, Beam SL, Brown SD, Jablonski KA, Elias EG. The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy. J Am Coll Surg 2003; 197:403-407.
Piérard GE, Piérard-Franchimont C, Henry C, Lapière M. The proliferative activity of cells of malignant melanomas. Am J Dermatopathol 1984; 6(Suppl. 1):317-324.
McCarthy WH, Shaw HM, McCarthy SW, Rivers JK, Thompson JF. Cutaneous melanomas that defy conventional prognostic indicators. Semin Oncol 1996; 23:709-713.
Thompson JF, Shaw HM. Sentinel node metastasis from thin melanomas with vertical growth phase. Ann Surg Oncol 2000; 7:251-252.
Fontaine D, Parkhill W, Greer W, Walsh N. Partial regression of primary cutaneous melanoma. Is there an association with subclinical sentinel lymph node metastasis? Am J Dermatopathol 2003; 25:371-376.
Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma: an immunohistochemical study. Am J Surg Pathol 1988; 12:612-618.
Rimoldi D, Lemoine R, Kurt AM, Salvi S, Berset M, Matter M, et al. Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods. Melanoma Res 2003; 13:511-520.
Barinaga M. New type of blood vessel found in tumors. Science 1999; 285:1475.